Phase II study of S‐1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART‐1501 study.

MLA

Fukuda, Minoru, et al. “Phase II Study of S‐1 plus Cisplatin with Concurrent Radiotherapy for Locally Advanced Thymic Carcinoma: Results of the LOGIK1605/JART‐1501 Study.” Thoracic Cancer, vol. 13, no. 17, Sept. 2022, pp. 2499–506. EBSCOhost, https://doi.org/10.1111/1759-7714.14586.

APA

Fukuda, M., Yamaguchi, M., Yamazaki, T., Funaki, S., Mukae, H., Fukuoka, J., Nabeshima, K., Tateyama, H., Ashizawa, K., Tomiyama, N., Hara, M., Seto, T., Okumura, M., & Sugio, K. (2022). Phase II study of S‐1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART‐1501 study. Thoracic Cancer, 13(17), 2499–2506. https://doi.org/10.1111/1759-7714.14586

Chicago

Fukuda, Minoru, Masafumi Yamaguchi, Takuya Yamazaki, Soichiro Funaki, Hiroshi Mukae, Junya Fukuoka, Kazuki Nabeshima, et al. 2022. “Phase II Study of S‐1 plus Cisplatin with Concurrent Radiotherapy for Locally Advanced Thymic Carcinoma: Results of the LOGIK1605/JART‐1501 Study.” Thoracic Cancer 13 (17): 2499–2506. doi:10.1111/1759-7714.14586.